UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis

PloS one, 2015-04, Vol.10 (4), p.e0125879-e0125879

2015

Volltextzugriff (PDF)

Mechanical endovascular therapy for acute ischemic stroke: An indirect treatment comparison between Solitaire and Penumbra thrombectomy devices

PloS one, 2018-03, Vol.13 (3), p.e0191657-e0191657

2018

Volltextzugriff (PDF)

Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression

Thrombosis journal, 2014-06, Vol.12 (1), p.14-14, Article 14

2014

Volltextzugriff (PDF)

Short-term consequences of angiographically-confirmed coronary stent thrombosis

PloS one, 2013-10, Vol.8 (10), p.e77330

2013

Volltextzugriff (PDF)

Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma

Journal of clinical oncology, 2017-04, Vol.35 (11), p.1194-1202

2017

Volltextzugriff (PDF)

Cost-Effectiveness of Ranolazine Added to Standard-of-Care Treatment in Patients With Chronic Stable Angina Pectoris

The American journal of cardiology, 2014-04, Vol.113 (8), p.1306-1311

2014

Volltextzugriff (PDF)

The non-medical switching of prescription medications

Postgraduate medicine, 2019-07, Vol.131 (5), p.335-341

2019

Volltextzugriff (PDF)

Prognostic Accuracy of Clinical Prediction Rules for Early Post-Pulmonary Embolism All-Cause Mortality

Chest, 2015-04, Vol.147 (4), p.1043-1062

2015

Volltextzugriff (PDF)

Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysis

Chest, 2015-04, Vol.147 (4), p.1043-1062

2015

Volltextzugriff (PDF)

Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient Sample

Atherosclerosis, 2019-07, Vol.286, p.142-146

2019

Volltextzugriff (PDF)

Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States

Breast cancer research and treatment, 2016-11, Vol.160 (1), p.187-196

2016

Volltextzugriff (PDF)

Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life

International journal of cardiology, 2018-12, Vol.273, p.34-38

2018

Volltextzugriff (PDF)

Humanistic and economic burden of hepatocellular carcinoma: systematic literature review

The American journal of managed care, 2019-02, Vol.25 (2 Spec No.), p.SP61

2019

Volltextzugriff (PDF)

Comparative risk of major bleeding with rivaroxaban and warfarin: Population‐based cohort study of unprovoked venous thromboembolism

European journal of haematology, 2019-02, Vol.102 (2), p.143-149

2019

Volltextzugriff (PDF)

External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancer

Supportive care in cancer, 2019-03, Vol.27 (3), p.921-925

2019

Volltextzugriff (PDF)

Derivation and validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule

Current medical research and opinion, 2015-08, Vol.31 (8), p.1461-1468

2015

Volltextzugriff (PDF)

Parameterization of a disease progression simulation model for sequentially treated metastatic human epidermal growth factor receptor 2 positive breast cancer patients

Current medical research and opinion, 2016-06, Vol.32 (6), p.991-996

2016

Volltextzugriff (PDF)

Estimating a minimal clinically important difference for the EuroQol 5-Dimension health status index in persons with multiple sclerosis

Health and quality of life outcomes, 2014-05, Vol.12 (1), p.66-66, Article 66

2014

Volltextzugriff (PDF)

Meta-Analysis to Assess the Quality of International Normalized Ratio Control and Associated Outcomes in Venous Thromboembolism Patients

Thrombosis research, 2014-08, Vol.134 (2), p.310-319

2014

Volltextzugriff (PDF)

Reply to Á. Benedict et al

Journal of clinical oncology, 2017-09, Vol.35 (26), p.3086-3087

2017

Volltextzugriff (PDF)

Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism

Pharmacotherapy, 2016-10, Vol.36 (10), p.1109-1115

2016

Volltextzugriff (PDF)

Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective

BMJ open, 2015-11, Vol.5 (11), p.e008861-e008861

2015

Volltextzugriff (PDF)

Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis

Journal of the National Comprehensive Cancer Network, 2018-05, Vol.16 (5), p.491-497

2018

Volltextzugriff (PDF)

Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolism

Blood advances, 2020-09, Vol.4 (17), p.4045-4051

2020

Volltextzugriff (PDF)

Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies

Current medical research and opinion, 2017-09, Vol.33 (9), p.1697-1703

2017

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(93)

Publikationsform

Artikel
(103)
Bücher
(3)

Sprache

Englisch
(105)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis

Mechanical endovascular therapy for acute ischemic stroke: An indirect treatment comparison between Solitaire and Penumbra thrombectomy devices

Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression

Short-term consequences of angiographically-confirmed coronary stent thrombosis

Cost-Effectiveness of Immune Checkpoint Inhibition in BRAF Wild-Type Advanced Melanoma

Cost-Effectiveness of Ranolazine Added to Standard-of-Care Treatment in Patients With Chronic Stable Angina Pectoris

The non-medical switching of prescription medications

Prognostic Accuracy of Clinical Prediction Rules for Early Post-Pulmonary Embolism All-Cause Mortality

Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysis

Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient Sample

Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive metastatic breast cancer in the United States

Ranolazine in patients with type 2 diabetes and chronic angina: A cost-effectiveness analysis and assessment of health-related quality-of-life

Humanistic and economic burden of hepatocellular carcinoma: systematic literature review

Comparative risk of major bleeding with rivaroxaban and warfarin: Population‐based cohort study of unprovoked venous thromboembolism

External validation of three risk stratification rules in patients presenting with pulmonary embolism and cancer

Derivation and validation of the In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule

Parameterization of a disease progression simulation model for sequentially treated metastatic human epidermal growth factor receptor 2 positive breast cancer patients

Estimating a minimal clinically important difference for the EuroQol 5-Dimension health status index in persons with multiple sclerosis

Meta-Analysis to Assess the Quality of International Normalized Ratio Control and Associated Outcomes in Venous Thromboembolism Patients

Reply to Á. Benedict et al

Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism

Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective

Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis

Effectiveness and safety of rivaroxaban compared with low-molecular-weight heparin in cancer-associated thromboembolism

Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies

Suchergebnisse filtern